Cancer drugs inhibit morphogenesis in the human fungal pathogen, Candida albicans

Candida infections are very common in cancer patients and it is a common practice to prescribe antifungal antibiotics along with anticancer drugs. Yeast to hyphal form switching is considered to be important in invasive candidiasis. Targeting morphogenetic switching may be useful against invasive ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Routh, Madhushree M, Chauhan, Nitin M, Karuppayil, S Mohan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Brazilian Society of Microbiology 2014
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3910200/
https://www.ncbi.nlm.nih.gov/pubmed/24516452
_version_ 1782301945864650752
author Routh, Madhushree M
Chauhan, Nitin M
Karuppayil, S Mohan
author_facet Routh, Madhushree M
Chauhan, Nitin M
Karuppayil, S Mohan
author_sort Routh, Madhushree M
collection PubMed
description Candida infections are very common in cancer patients and it is a common practice to prescribe antifungal antibiotics along with anticancer drugs. Yeast to hyphal form switching is considered to be important in invasive candidiasis. Targeting morphogenetic switching may be useful against invasive candidiasis. In this study, we report the antimorphogenetic properties of thirty cancer drugs.
format Online
Article
Text
id pubmed-3910200
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Brazilian Society of Microbiology
record_format MEDLINE/PubMed
spelling pubmed-39102002014-02-15 Cancer drugs inhibit morphogenesis in the human fungal pathogen, Candida albicans Routh, Madhushree M Chauhan, Nitin M Karuppayil, S Mohan Braz J Microbiol Short Communication Candida infections are very common in cancer patients and it is a common practice to prescribe antifungal antibiotics along with anticancer drugs. Yeast to hyphal form switching is considered to be important in invasive candidiasis. Targeting morphogenetic switching may be useful against invasive candidiasis. In this study, we report the antimorphogenetic properties of thirty cancer drugs. Brazilian Society of Microbiology 2014-01-15 /pmc/articles/PMC3910200/ /pubmed/24516452 Text en Copyright © 2013, Sociedade Brasileira de Microbiologia All the content of the journal, except where otherwise noted, is licensed under a Creative Commons License CC BY-NC.
spellingShingle Short Communication
Routh, Madhushree M
Chauhan, Nitin M
Karuppayil, S Mohan
Cancer drugs inhibit morphogenesis in the human fungal pathogen, Candida albicans
title Cancer drugs inhibit morphogenesis in the human fungal pathogen, Candida albicans
title_full Cancer drugs inhibit morphogenesis in the human fungal pathogen, Candida albicans
title_fullStr Cancer drugs inhibit morphogenesis in the human fungal pathogen, Candida albicans
title_full_unstemmed Cancer drugs inhibit morphogenesis in the human fungal pathogen, Candida albicans
title_short Cancer drugs inhibit morphogenesis in the human fungal pathogen, Candida albicans
title_sort cancer drugs inhibit morphogenesis in the human fungal pathogen, candida albicans
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3910200/
https://www.ncbi.nlm.nih.gov/pubmed/24516452
work_keys_str_mv AT routhmadhushreem cancerdrugsinhibitmorphogenesisinthehumanfungalpathogencandidaalbicans
AT chauhannitinm cancerdrugsinhibitmorphogenesisinthehumanfungalpathogencandidaalbicans
AT karuppayilsmohan cancerdrugsinhibitmorphogenesisinthehumanfungalpathogencandidaalbicans

Ejemplares similares